Fluidigm Corporation (FLDM)
(Delayed Data from NSDQ)
$11.89 USD
-1.80 (-13.15%)
Updated May 3, 2019 04:00 PM ET
After-Market: $11.89 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.89 USD
-1.80 (-13.15%)
Updated May 3, 2019 04:00 PM ET
After-Market: $11.89 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Akers Receives Cholesterol Test Kit Order from First Check
by Zacks Equity Research
Akers Biosciences, Inc. (AKER) announced that it has received an initial order under the distribution agreement for its rapid cholesterol self-test kit.
Henry Schein (HSIC) Poised on Solid Growth, Risks Remain
by Zacks Equity Research
On Mar 27, we issued an updated research report on Melville, NY-based Henry Schein, Inc. (HSIC).
BioScrip (BIOS) Stock Declines on Dull Q1 EBITDA Outlook
by Zacks Equity Research
Bioscrip, Inc.'s (BIOS) shares witnessed a 2.2% fall in yesterday's trading session, closing at $1.78.
Evolent Health (EVH) Prices 7.5M Follow-On Share Offering
by Zacks Equity Research
Evolent Health, Inc. (EVH) announced the pricing of its follow-on public offering of 7.5 million shares of Class A common stock at $21.25 per share.
DexCom Gains as CMS Announces Criteria for G5 Mobile CGM
by Zacks Equity Research
The Centers for Medicare & Medicaid Services published an article clarifying the criteria for coverage of its DexCom (DXCM) G5 Mobile CGM system for patients with diabetes and on intensive insulin therapy.
Ecolab (ECL) Teams Up with Microsoft to Upgrade Water Tool
by Zacks Equity Research
Ecolab Inc. (ECL) announced that it has collaborated with Microsoft Corp. (MSFT) to upgrade its financial-modeling tool, Water Risk Monetizer.
Medidata Clinical Cloud Selected for AML Master Trial by LLS
by Zacks Equity Research
Medidata Solutions Inc. (MDSO) announced that The Leukemia & Lymphoma Society selected Medidata Clinical Cloud platform for diagnosis and treatment of acute myeloid leukemia (AML) through a clinical trial known as the Beat AML Master Trial.
The Cooper Companies Hits 52-Week High on Multiple Positives
by Zacks Equity Research
Shares of Pleasanton, CA-based The Cooper Companies (COO) rallied to a new 52-week high of $202.70 on Mar 23, closing a tad lower at $199.70.
Merit Medical (MMSI) Prices 4.5M Follow-On Share Offering
by Zacks Equity Research
Merit Medical Systems, Inc. (MMSI) announced that it has priced its follow-on public offering of 4.5 million shares of common stock at $28.25 per share.
Cooper Companies (COO) Increase Share Repurchase Program
by Zacks Equity Research
The Cooper Companies, Inc. (COO) recently announced that it has approved a $500.0 million increase in its ongoing share repurchase program.
HealthEquity (HQY) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
HealthEquity Inc (HQY) reported earnings of 7 cents per share in the fourth quarter of 2016, higher than the Zacks Consensus Estimate of 5 cents.
DENTSPLY Sirona Grapples with Multiple Issues: Dump Now?
by Zacks Equity Research
On Mar 20, we issued an updated research report on NY-based DENTSPLY Sirona Inc. (XRAY) -- a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products.
Neogen (NEOG) Earnings and Revenues Meet Estimates in Q3
by Zacks Equity Research
Neogen Corp (NEOG) reported adjusted earnings of 27 cents per share in the third quarter of fiscal 2017. The figure was in line with the Zacks Consensus Estimate and increased 22.7% from the year-ago quarter.
Merit Medical (MMSI) to Refinance Debt via Share Offering
by Zacks Equity Research
Merit Medical Systems, Inc. (MMSI) announced that it has commenced a follow on public offering of its common stock.
Mazor Robotics-Medtronic's Mazor X Partnership Strengthens
by Zacks Equity Research
Mazor Robotics (MZOR) recently announced that its strategic partnership with Medtronic Plc. (MDT) for the commercialization and co-promotion of Mazor X platform, an innovative guidance system for spine surgery, is going strong.
Fresenius (FMS) to Jointly Develop Acumen with Epic Systems
by Zacks Equity Research
Fresenius Medical Care AG & Co. KGAA (FMS) announced that it would jointly develop Acumen 2.0 with Epic Systems Corporation.
PharMerica Takes Over CareMed, Expands in Specialty Pharmacy
by Zacks Equity Research
PharMerica Corporation (PMC) recently announced the acquisition of CareMed Specialty Pharmacy, a leading provider of specialty pharmacy services. However, all the other terms of the deal have been kept under wraps.
Air Methods (AIRM) Opens New Training Facility in Colorado
by Zacks Equity Research
Air Methods Corporation (AIRM) announced the opening of new FlightSafety Learning Center in Denver, CO.
Patterson (PDCO) Rewards Shareholders with 8% Dividend Hike
by Zacks Equity Research
Patterson Companies Inc. (PDCO) recently hiked its quarterly dividend by 8% to 26 cents per share from 24 cents.
Air Methods (AIRM) Set to be Acquired for $2.5 Billion
by Zacks Equity Research
Air Methods Corporation (AIRM) announced that it is set to be acquired by New York-based private equity firm American Securities LLC for $2.5 billion.
AngioDynamics Microwave Tissue Ablation System Now CE Marked
by Zacks Equity Research
AngioDynamics Inc. (ANGO), a leading provider of minimally invasive medical devices, recently announced the receipt of CE mark for Solero Microwave Tissue Ablation (MTA) System.
Stryker Launches MAKO Robotic-Arm for Knee Anthroplasty
by Zacks Equity Research
Stryker Corporation (SYK) recently announced the commercial launch of a robotic-arm assisted total knee arthroplasty application based on its flagship MAKO System.
ABIOMED Impella Heart Pump Reduces Kidney Injury during PCI
by Zacks Equity Research
A new study demonstrates that ABIOMED's flagship Impella 2.5 heart pump can reduce the risk of acute kidney injury during high-risk percutaneous coronary intervention (PCI).
Cogentix (CGNT) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Cogentix Medical, Inc. (CGNT) reported adjusted loss of 14 cents per share in the fourth quarter of 2016.
Cooper Companies (COO) Receives ISO 15189 Accreditation
by Zacks Equity Research
The Cooper Companies Inc. (COO) announced that its London and Nottingham-based laboratories received the International Organization for Standardization 15189 accreditation.